JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 21, 2006; DOI: 10.1124/jpet.105.100537


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.100537v1
318/1/186    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raphael, J.
Right arrow Articles by Gozal, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raphael, J.
Right arrow Articles by Gozal, Y.


Received for publication December 27, 2005.
Revised March 18, 2006.
Accepted for publication March 21, 2006.

Volatile Anesthetic Preconditioning Attenuates Myocardial Apoptosis in Rabbits after Regional Ischemia and Reperfusion via Akt Signaling and Modulation of Bcl-2 Family Proteins

Jacob Raphael 1*, Suzan Abedat 2, Julia Rivo 2, Karen Meir 2, Ronen Beeri 2, Thea Pugatsch 2, Zhiyi Zuo 3, Yaacov Gozal 2

1 University of Virginia 2 Hadassah University Hospital 3 University of virginia

* Address correspondence to: E-mail: jr5ef{at}virginia.edu

Abstract

We tested whether isoflurane preconditioning inhibits cardiomyocyte apoptosis and evaluated the role of the phosphatidylinositol-3-kinase (PI3K)/Akt pathway in anesthetic preconditioning and determined whether (PI3K)/Akt signaling modulates the expression of pro- and anti-apoptotic proteins in anesthetic preconditioning. Six-months old New-Zealand rabbits subjected to 40 minutes of myocardial ischemia followed by 180 minutes of reperfusion, were assigned to the following groups: ischemia-reperfusion (I/R), isoflurane preconditioning and isoflurane plus PI3K inhibitors: wortmannin and LY294002 (0.6 mg/kg, 0.3 mg/kg intravenously, respectively). Sham-operated, wortmannin + I/R, wortmannin + sham, LY294002 + I/R and LY294002 + sham groups were also included. Infarct size was assessed by triphenyltetrazolium chloride staining. Apoptosis was evaluated by TUNEL and activated caspase-3 assays. Akt phosphorylation, Bax, Bcl-2, Bad and phospho-Bad expression was assessed by immunoblotting. Isoflurane preconditioning reduced infarct size compared to the I/R group: 22±4% vs. 41±5% (p<0.05). The percentage of apoptotic cells decreased in the isoflurane group (3.8±1.2%) compared to I/R group (12.4±1.6%; p<0.05). These results were also confirmed by the activated caspase-3 assay. Wortmannin and LY294002 inhibited the effects of isoflurane: myocardial infarction increased to 44±3% and 45±2% and the percentage of apoptotic cells was 11.9±2.1% and 11.7±3.3% respectively. Akt phosphorylation, Bcl-2 and phospho-Bad expression increased after isoflurane preconditioning, while Bax expression decreased. These effects were inhibited by wortmannin and LY294002. The data indicate that isoflurane preconditioning reduces infarct size and myocardial apoptosis after I/R. Activation of PI3K and modulation of the expression of pro- and anti-apoptotic proteins may play a role in isoflurane-induced myocardial protection.


Key words: Anesthetics, Apoptosis, Ischemia, PI3K, Preconditioning, Reperfusion


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
P. S. Pagel
Induction of Heat Shock Protein 70 and Preconditioning by Sevoflurane: A Potent Protective Interaction Against Myocardial Ischemia-Reperfusion Injury
Anesth. Analg., September 1, 2008; 107(3): 742 - 745.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. K. Singla, R. D. Singla, and D. E. McDonald
Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H907 - H913.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.